Bridging the Genomic Epidemiological Gap for priority Salmonella serovars through genomic characterization and nomenclature development


Funding period: 2017-2019
Lead: Roger Johnson
Total GRDI funding: $200,000

Nearly 60% of human Salmonellosis cases in Canada can be attributed to four Salmonella enterica serovars. The high rate of human infection with these serovars makes them highly significant targets for developing more effective subtyping methods and comprehensive information on the population structure that will enhance capacity for outbreak detection and source attribution. Before we can analyse the Canadian population structure of these serovars, new whole genome sequence (WGS) data are needed to provide the necessary Canadian context to understand the circulating populations. This project will then analyse the new and existing WGS data to develop a nomenclature for precise subtyping.

Contact us

For additional information, please contact:
Genomics R&D Initiative